Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 30, 2024
This
study
examined
the
incidence,
characteristics,
and
risk
factors
of
new
gastrointestinal
disorders
(GID)
associated
with
SARS-CoV-2
infection
up
to
3.5
years
post-infection.
retrospective
included
35,102
COVID-19
patients
682,594
contemporary
non-COVID-19
without
past
medical
history
GID
(controls)
from
Montefiore
Health
System
in
Bronx
(3/1/2020
7/31/2023).
Comparisons
were
made
unmatched
propensity-matched
(1:2)
controls.
The
primary
outcome
was
which
peptic
ulcer,
inflammatory
bowel
disease,
irritable
syndrome,
diverticulosis,
diverticulitis,
biliary
disease.
Multivariate
Cox
proportional
hazards
model
analysis
performed
adjustment
for
covariates.
There
2,228
(6.34%)
positive
who
developed
compared
38,928
(5.70%)
had
an
elevated
developing
(adjusted
HR
=
1.18
(95%
CI
1.12-1.25)
controls,
after
adjusting
confounders
that
smoking,
obesity,
diabetes,
hypertension.
These
findings
underscore
need
additional
research
follow-up
at-risk
individuals
post
infection.
Diseases,
Journal Year:
2024,
Volume and Issue:
12(6), P. 123 - 123
Published: June 5, 2024
Background:
The
long-term
survival
of
patients
hospitalized
with
COVID-19
and
the
factors
associated
poorer
months
after
infection
are
not
well
understood.
aims
present
study
were
to
analyze
overall
mortality
10
admission.
Methods:
762
disease
included.
Patients
underwent
a
complete
clinical
evaluation,
routine
laboratory
analysis
chest
X-ray.
Data
collected
included
demographic
data,
such
as
vascular
risk
factors,
tobacco
or
alcohol
use,
comorbidity,
institutionalization.
Results:
Ten-month
was
25.6%:
108
deaths
occurred
in-hospital,
while
87
died
discharge.
In-hospital
independently
related
NT-proBNP
values
>
503.5
pg/mL
[OR
=
4.67
(2.38–9.20)],
urea
37
mg/dL
[3.21
(1.86–7.31)]
age
older
than
71
years
1.93
(1.05–3.54)].
5.00
(3.06–8.19)],
[3.51
(1.97–6.27)],
cognitive
impairment
1.96
(1.30–2.95),
cancer
2.23
(1.36–3.68),
leukocytes
6330/mm3
1.64
(1.08–2.50)],
mortality.
Conclusions:
death
remains
high
even
infection.
Overall
during
hospital
discharge
is
nearly
that
observed
Comorbidities
impairment,
organ
dysfunction
inflammatory
reaction
independent
prognostic
markers
Diagnostics,
Journal Year:
2024,
Volume and Issue:
14(24), P. 2774 - 2774
Published: Dec. 10, 2024
Although
COVID-19
has
been
linked
to
worse
outcomes
in
patients
with
neurological
disorders,
its
impact
on
those
essential
tremor
(ET)
remains
unclear.
To
investigate
clinical
of
ET
and
without
three
a
half
years
post-pandemic.
1074
were
evaluated
this
retrospective
study
the
Montefiore
Health
System
from
January
2016
July
2023.
Comparisons
between
positive
SARS-CoV-2
polymerase
chain
reaction
test
made.
Outcomes
included
post-index
date
major
adverse
cardiovascular
events
(MACEs),
new-onset
sleep
disturbances,
fatigue,
dyspnea,
first-time
fall,
anxiety,
depression,
headache,
imbalance,
mild
cognitive
impairment,
all-cause
mortality,
adjusted
hazard
ratios
(aHR)
adjusting
for
covariates
calculated.
had
higher
prevalence
pre-existing
type-2
diabetes,
anxiety
compared
COVID-19.
was
significantly
associated
risk
MACEs,
(aHR
=
2.39
[1.49,
3.82]),
disturbance,
2.12
[1.44,
3.13]),
1.83
[1.27,
2.65]),
1.98
[1.40,
2.80]),
4.76
[2.24,
10.14]),
3.66
[2.02,
6.64]),
2.38
[1.20,
4.70]).
not
mortality.
In
ET,
increases
several
long-term
health
outcomes,
but
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 30, 2024
This
study
examined
the
incidence,
characteristics,
and
risk
factors
of
new
gastrointestinal
disorders
(GID)
associated
with
SARS-CoV-2
infection
up
to
3.5
years
post-infection.
retrospective
included
35,102
COVID-19
patients
682,594
contemporary
non-COVID-19
without
past
medical
history
GID
(controls)
from
Montefiore
Health
System
in
Bronx
(3/1/2020
7/31/2023).
Comparisons
were
made
unmatched
propensity-matched
(1:2)
controls.
The
primary
outcome
was
which
peptic
ulcer,
inflammatory
bowel
disease,
irritable
syndrome,
diverticulosis,
diverticulitis,
biliary
disease.
Multivariate
Cox
proportional
hazards
model
analysis
performed
adjustment
for
covariates.
There
2,228
(6.34%)
positive
who
developed
compared
38,928
(5.70%)
had
an
elevated
developing
(adjusted
HR
=
1.18
(95%
CI
1.12-1.25)
controls,
after
adjusting
confounders
that
smoking,
obesity,
diabetes,
hypertension.
These
findings
underscore
need
additional
research
follow-up
at-risk
individuals
post
infection.